TC BIOPHARM HOLDINGS PLC-ADR (TCBP)

US87807D4007 - ADR

0.66  +0 (+0.15%)

After market: 0.65 -0.01 (-1.52%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
1.98M
-42.27%		1.98M3.84M
93.94%		2.018M
-100.00%
EBITDA
YoY % growth
-5.82M
-2.46%		-6.29M
-8.08%		-10.95M
-74.09%		N/A
-24.26%		N/AN/A
EBIT
YoY % growth
-6.89M
-4.71%		-7.31M
-6.10%		-11.92M
-63.06%		-24.094M
-19.46%		N/AN/A
Operating Margin
-347.98%-369.19%-310.42%-1,193.98%N/AN/A
EPS
YoY % growth
N/AN/AN/A-4.69
99.80%		-0.01
99.78%		0.00
100.00%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23 Q1 / 24
EPS
Q2Q % growth		-0.81
99.93%		-0.71
99.37%		N/A
Revenue
Q2Q % growth		504.9K504.9K
-86.87%		N/A
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-5.514M
-8.01%		-5.616M
52.89%		N/A

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 3.845M
684.60%		504.9K3.34M661.44%
Q3 2022
Q2Q % growth
3.04%		504.9K%
Q2 2022
Q2Q % growth		 989K
-0.03%		%
Q4 2021
Q2Q % growth		 490K %
Q3 2021
Q2Q % growth		 490K %
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% N/A N/A
Revenue0% 0% N/A N/A